Literature DB >> 15155223

Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance.

L Temime1, D Guillemot, P Y Boëlle.   

Abstract

Recent observations have shown that wide-scale vaccination with pneumococcal conjugate vaccines was associated with a reduction in invasive disease, supporting the expectation that vaccination could help reduce carriage of Streptococcus pneumoniae and control the spread of resistant strains. However, it is too early to assess whether these effects can be sustained in the long term. Here, we used mathematical modeling to investigate time changes in pneumococcal colonization and resistance induced by conjugate vaccination in an environment where antibiotic exposure is high and resistance is widespread. According to model predictions, vaccination induced a decrease in carriage of vaccine-type pneumococci to very low levels, typically in 10 to 15 years under epidemiologically realistic conditions. Almost simultaneously, non-vaccine-type pneumococci spread in the community. Consequently, while there was a short-term decrease in the overall carriage rate, it was followed after a few years by a renewed, although limited, increase. Vaccination with a heptavalent vaccine did not affect the extent to which antibiotic resistance was selected: in all cases, the distribution of resistance levels peaked at high levels (MIC > 2 microg/ml) after 20 years. With a vaccine optimally designed to include all serotypes currently exhibiting decreased susceptibility to penicillin G, the selection of resistance was slowed down, although not prevented. These results suggest that because of serotype replacement, the effects of vaccination observed today may not be sustained in the long term. As a consequence, vaccination alone may not be successful in controlling selection for resistance in S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155223      PMCID: PMC415598          DOI: 10.1128/AAC.48.6.2206-2213.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

Authors:  B G Spratt; B M Greenwood
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

Authors:  Ron Dagan; Noga Givon-Lavi; Orly Zamir; Merav Sikuler-Cohen; Lior Guy; Jacob Janco; Pablo Yagupsky; Drora Fraser
Journal:  J Infect Dis       Date:  2002-03-04       Impact factor: 5.226

3.  Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage.

Authors:  J Raymond; I Le Thomas; F Moulin; A Commeau; D Gendrel; P Berche
Journal:  J Infect Dis       Date:  2000-05-22       Impact factor: 5.226

4.  Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.

Authors:  R Dagan; M Sikuler-Cohen; O Zamir; J Janco; N Givon-Lavi; D Fraser
Journal:  Pediatr Infect Dis J       Date:  2001-10       Impact factor: 2.129

Review 5.  The potential indirect effect of conjugate pneumococcal vaccines.

Authors:  Katherine L O'Brien; Ron Dagan
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

6.  Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.

Authors:  J P Metlay; J Hofmann; M S Cetron; M J Fine; M M Farley; C Whitney; R F Breiman
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

Review 7.  Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management.

Authors:  Keith Cartwright
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

8.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 9.  Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.

Authors:  K P Klugman
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

10.  Bacterial resistance to penicillin G by decreased affinity of penicillin-binding proteins: a mathematical model.

Authors:  L Temime; P Y Boëlle; P Courvalin; D Guillemot
Journal:  Emerg Infect Dis       Date:  2003-04       Impact factor: 6.883

View more
  17 in total

1.  Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine.

Authors:  Damien M O'halloran; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong.

Authors:  Margaret Ip; E Anthony S Nelson; Edmund S C Cheuk; Rita Y T Sung; Albert Li; Helen Ma; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

3.  Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.

Authors:  R Dias; M Caniça
Journal:  Epidemiol Infect       Date:  2007-08-16       Impact factor: 2.451

Review 4.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

5.  Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.

Authors:  Uri Obolski; José Lourenço; Craig Thompson; Robin Thompson; Andrea Gori; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

6.  Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya.

Authors:  Osman Abdullahi; Angela Karani; Caroline C Tigoi; Daisy Mugo; Stella Kungu; Eva Wanjiru; Jane Jomo; Robert Musyimi; Marc Lipsitch; J Anthony G Scott
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

Review 7.  Emerging vaccine informatics.

Authors:  Yongqun He; Rino Rappuoli; Anne S De Groot; Robert T Chen
Journal:  J Biomed Biotechnol       Date:  2011-06-15

8.  Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review.

Authors:  D E Ramsay; J Invik; S L Checkley; S P Gow; N D Osgood; C L Waldner
Journal:  Epidemiol Infect       Date:  2018-07-31       Impact factor: 4.434

9.  S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools.

Authors:  Simon Cauchemez; Laura Temime; Alain-Jacques Valleron; Emmanuelle Varon; Guy Thomas; Didier Guillemot; Pierre-Yves Boëlle
Journal:  BMC Infect Dis       Date:  2006-01-30       Impact factor: 3.090

10.  Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.

Authors:  Lulla Opatowski; Laura Temime; Emmanuelle Varon; Roland Leclercq; Roland Leclerc; Henri Drugeon; Pierre-Yves Boëlle; Didier Guillemot
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.